Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: Misuse or abuse?

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 11, 2007, Pages 1173-1182

  Güven, Ayla ^a,b,c   Gülütimser, Özlem ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Cemil Akdo an Sokak Toprak   (Turkey)

Author keywords

Adrenal insufficiency; Clobetasol propionate; Cushing's syndrome; Diflucortolone valerate; Infant

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CLOBETASOL PROPIONATE; CORTICOSTEROID; CORTICOTROPIN; CYANOCOBALAMIN; DIFLUCORTOLONE VALERATE; GLUCOCORTICOID; HYDROCORTISONE; ISOCONAZOLE; LIPID; STEROID; TRAVAZOL; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADRENAL CORTEX INSUFFICIENCY; ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN TEST; CUSHING SYNDROME; CYANOCOBALAMIN DEFICIENCY; DIAPER DERMATITIS; DRUG ABUSE; DRUG DOSE REDUCTION; DRUG MISUSE; DRUG WITHDRAWAL; FATTY LIVER; FEMALE; HEPATOMEGALY; HEPATOSPLENOMEGALY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; INFANT DISEASE; LIPID BLOOD LEVEL; MALE; SIDE EFFECT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WITHDRAWAL SYNDROME;

EID: 37349043235     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.11.1173     Document Type: Article

References (31)

1. Borzyskowski M, Grant DB, Wells RS. Cushing's syndrome induced by topical steroids used for the treatment of non-bullous ichthyosiform erythroderma. Clin Exp Dermatol 1976; 1: 337-342.
2. Romano PE, Traisman HS, Green OC. Fluorinated corticosteroid toxicity in infants. Am J Ophthalmol 1977; 84: 247-250.
3. Ronayette D, Hennequin D, Bouquier JJ, Bonnetblanc JM. Cushing's syndrome induced by local corticotherapy in an infant. Nouv Presse Med 1978; 7: 368.
4. Curtis JA, Cormode E, Laski B, Toole J, Howard N. Endocrine complications of topical and intralesional corticosteroid therapy. Arch Dis Child 1982; 57: 204-207.
5. Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C. Cushing's syndrome after topical application of corticosteroids. Am J Dis Child 1982; 136: 274-275.
6. Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C. Potential hazards of topical steroid therapy. Am J Dis Child 1983; 137: 1130-1131.
7. Ermis B, Ors R, Tastekin A, Ozkan B. Cushing's syndrome secondary to topical corticosteroids abuse. Clin Endocrinol 2003; 58: 795-796.
8. Cherian MP, Abduljabbar M. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants. Saudia Med J 2001; 22: 1139-1141.
9. Siklar Z, Bostanci I, Atli Ö, Dallar Y. An infantile Cushing's syndrome due to misuse of topical steroid. Pediatr Dermatol 2004; 21: 561-563.
10. Dandine M, Lavaud J, Besson-Leaud M, Limal JM. Adrenal insufficiency and iatrogenic Cushing's syndrome due to percutaneous absorption of corticosteroids in an 8-month-old infant. Ann Dermatol Venereol 1980; 107: 191-195.
11. Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch Dis Child 2004; 89: 648-652.
12. Güven A, Karadeniz S, Aydin O, Akbalik M, Aydin M. Fatal disseminated Cytomegalovirus infection in an infant with Cushing's syndrome caused by topical steroid. Horm Res 2005; 64: 35-38.
13. Christensen B, Glueck C, Kwiterovich P, Degroot I, Chase G, Heiss G, Mowery R, Tamir I, Rifkind B. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the Prevalence Study of the Lipid Research Clinics Program. Pediatr Res 1980; 14: 194-202.
14. Grinspoon SK, Biller BM. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79:923-931.
15. Gonc EN, Kandemir N, Kinik ST. Significance of low-dose and standard-dose ACTH tests compared to overnight metyrapone test in the diagnosis of adrenal insufficiency in childhood. Horm Res 2003; 60: 191-197.
16. Forest MG. Adrenal function test. In: Ranke MB, ed. Diagnostics of Endocrine Function in Children and Adolescents, 3rd Ed. Basel: Karger, 2003; 372-426.
17. Carillo AA, Chasalow F. Hormone measurements and dynamic tests in pediatric endocrinology. In: Lifshitz F, ed. Pediatric Endocrinology, 4th Ed. New York: Marcel Dekker, 2003; 935-955.
18. Shulman DI, Palmert MR, Kemp SF; Lawson Wilkins Drug and Therapeutics Committee. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics 2007; 119: e484-494.
19. Tümer N, Yalçinkaya F, Ince E, Ekim M, Köse K, Çakar N, Kara N, Özkaya N, Ensari C, Önder S. Blood pressure nomograms for children and adolescents in Turkey. Pediatr Nephrol 1999; 13: 438-443.
20. Olsen EA, Cornell R. Topical clobetasol-17-prupionate: review of its clinical efficacy and safety. J Am Acad Dermatol 1986; 15: 246-255.
21. Harris DW, Hunter JA. The use and abuse of 0.05% clobetasol propionate in dermatology. Dermatol Clin 1988; 6: 643-647.
22. http://dermnetnz.org/treatments/topical-steroids.html
23. Hochberg Z, Pacak K, Chrousos GP. Endocrine withdrawal syndromes. Endocr Rev 2003; 24: 523-538.
24. Kaplowitz N, DeLeve LD. Drug-Induced Liver Disease. New York: Marcel Dekker, 2003; pp 694.
25. Baldridge AD, Perez-Atayde AR, Graeme-Cook F, Higgins L, Lavine JE. Idiopathic steatohepatitis in childhood: a multi-center retrospective study. J Pediatr 1995; 127: 700-704.
26. Marion AW, Baker AJ, Dhawan A. Fatty liver disease in children. Arch Dis Child 2004; 89: 648-652.
27. Sherlock S, Dooley J. Disease of the Liver and Biliary System, 11th Ed. Chapter 25: Nutritional and metabolic liver disease. Oxford: Blackwell, 2002; 423-431.
28. Candelli M, Nista EC, Pignataro G, Zannoni G,. de Pascalis B, Gasbarrini G, Gasbarrini A. Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation. J Intern Med 2003; 253: 391-392.
29. Huttunen N-P, Anttinen J, Kaira P, Koskimies O. An 8-year-old girl with nephritic syndrome, delayed response to prednisolone, and fatty liver. Pediatr Nephrol 1997; 11: 258-260.
30. Abraham G, Gottschalk J, Ungemach FR. Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function. Endocrinology 2005; 146:3163-3171.
31. Botero D, Mango A, Danon M, Lifshitz F. Lipid profile in congenital adrenal hyperplasia. Metabolism 2000; 49: 790-793.